Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture
May 29
French (CAC) Healthcare Sector Analysis
UpdatedMay 30, 2024
DataAggregated Company Financials
Companies64
- 7D-3.2%
- 3M-0.9%
- 1Y-0.5%
- YTD-0.9%
Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by Sanofi declining 2.4%. Meanwhile, Ramsay Générale de Santé actually outperformed within the industry, gaining 8.5% in the last week. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 15% annually.
Sector Valuation and Performance
Has the French Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 May 2024 | €266.3b | €110.0b | €9.0b | 24.2x | 29.5x | 2.4x |
| Sat, 27 Apr 2024 | €270.7b | €105.0b | €7.6b | 22.8x | 35.5x | 2.6x |
| Mon, 25 Mar 2024 | €276.1b | €104.7b | €8.6b | 21x | 32.1x | 2.6x |
| Wed, 21 Feb 2024 | €263.6b | €104.6b | €9.0b | 20.2x | 29.1x | 2.5x |
| Fri, 19 Jan 2024 | €264.2b | €104.0b | €12.7b | 21.4x | 20.8x | 2.5x |
| Sun, 17 Dec 2023 | €259.1b | €104.0b | €12.7b | 20.5x | 20.4x | 2.5x |
| Tue, 14 Nov 2023 | €245.8b | €104.0b | €12.7b | 20.1x | 19.4x | 2.4x |
| Thu, 12 Oct 2023 | €270.1b | €104.8b | €12.5b | 19.9x | 21.6x | 2.6x |
| Sat, 09 Sep 2023 | €275.4b | €104.9b | €12.4b | 21.8x | 22.3x | 2.6x |
| Mon, 07 Aug 2023 | €269.3b | €104.5b | €12.5b | 21.7x | 21.5x | 2.6x |
| Wed, 05 Jul 2023 | €265.6b | €103.8b | €12.4b | 19.3x | 21.4x | 2.6x |
| Fri, 02 Jun 2023 | €262.7b | €108.3b | €12.1b | 20.2x | 21.7x | 2.4x |
| Sun, 30 Apr 2023 | €274.7b | €108.3b | €12.1b | 21.2x | 22.8x | 2.5x |
| Tue, 28 Mar 2023 | €270.4b | €107.8b | €12.4b | 19.9x | 21.8x | 2.5x |
| Thu, 23 Feb 2023 | €269.3b | €106.2b | €10.9b | 18.1x | 24.8x | 2.5x |
| Sat, 21 Jan 2023 | €267.9b | €104.9b | €10.5b | 18.1x | 25.5x | 2.6x |
| Mon, 19 Dec 2022 | €260.2b | €104.9b | €10.5b | 17.1x | 24.8x | 2.5x |
| Wed, 16 Nov 2022 | €264.7b | €105.0b | €10.2b | 17.4x | 25.9x | 2.5x |
| Fri, 14 Oct 2022 | €245.0b | €102.5b | €10.4b | 17.1x | 23.7x | 2.4x |
| Sun, 11 Sep 2022 | €189.3b | €79.0b | €9.0b | 20.7x | 21x | 2.4x |
| Tue, 09 Aug 2022 | €211.1b | €78.9b | €9.1b | 21.5x | 23.1x | 2.7x |
| Thu, 07 Jul 2022 | €207.1b | €76.6b | €9.1b | 19.7x | 22.8x | 2.7x |
| Sat, 04 Jun 2022 | €211.1b | €76.4b | €9.2b | 20x | 23x | 2.8x |
| Mon, 02 May 2022 | €212.0b | €75.6b | €9.2b | 19x | 23x | 2.8x |
| Wed, 30 Mar 2022 | €211.3b | €74.3b | €8.7b | 21.7x | 24.3x | 2.8x |
| Fri, 25 Feb 2022 | €200.1b | €73.2b | €8.4b | 18.7x | 23.9x | 2.7x |
| Sun, 23 Jan 2022 | €211.2b | €71.8b | €8.5b | 20.8x | 24.8x | 2.9x |
| Tue, 21 Dec 2021 | €221.6b | €71.7b | €8.5b | 23.5x | 26x | 3.1x |
| Thu, 18 Nov 2021 | €228.9b | €71.8b | €8.5b | 23.6x | 26.9x | 3.2x |
| Sat, 16 Oct 2021 | €216.7b | €70.5b | €8.1b | 21.5x | 26.7x | 3.1x |
| Mon, 13 Sep 2021 | €222.9b | €70.2b | €8.1b | 25.5x | 27.5x | 3.2x |
| Wed, 11 Aug 2021 | €222.7b | €70.2b | €8.1b | 27.9x | 27.5x | 3.2x |
| Sun, 06 Jun 2021 | €204.0b | €68.5b | €14.2b | 28x | 14.4x | 3x |
Price to Earnings Ratio
14.4x
Current Industry PE
- Investors are optimistic on the French Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 29.9x which is higher than its 3-year average PE of 24.1x.
- The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 14% per year over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the French Healthcare sector?
| FR Market | -2.01% | |
| Healthcare | -3.22% | |
| Healthtech | 3.92% | |
| Medical Equipment | -2.30% | |
| Biotech | -2.70% | |
| Pharma | -3.20% | |
| Healthcare Services | -5.55% | |
| Life Sciences | -6.48% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 39.2x.
- Analysts are expecting annual earnings growth of 22.2%, which is higher than its past year's earnings decline of 55.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 22% over the next 5 years.
- This is better than its past earnings decline of 56% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings decline by 36% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GDS Ramsay Générale de Santé | €15.50 | 10.3% +€160.0m | -22.9% | PS0.4x | |
| EQS Equasens Société anonyme | €64.70 | 4.4% +€40.6m | -16.3% | PE20.1x | |
| MEDCL MedinCell | €15.50 | 8.4% +€34.9m | 127.9% | PS31.9x | |
| GNFT Genfit | €4.72 | 13.6% +€28.1m | 25.1% | PS6.8x | |
| BOI Boiron | €35.10 | 3.5% +€20.8m | -7.4% | PE17x |
